Send us Feedback

GlaxoSmithKline (GSK)
Analysis
Data
Financials
(Latest | Earliest) View (previous 50) (next 50)

Show WikiData History

Diff selection: mark the radio boxes of the versions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with current version, (last) = difference with preceding version, M = minor edit.

(cur)(last)14:10, November 12, 2009Wraasch (Talk | contribs)[stable]
(cur)(last)14:03, November 12, 2009155.91.28.231 (Talk) (→Products and Revenue)[stable]
(cur)(last)14:01, November 12, 2009155.91.28.231 (Talk) (→Corporate Overview)[stable]
(cur)(last)15:13, November 8, 2009Wraasch (Talk | contribs) (→Business Growth)[stable]
(cur)(last)11:51, October 10, 2009Wraasch (Talk | contribs)[stable]
(cur)(last)11:33, October 10, 2009Wraasch (Talk | contribs)m (→Patent expirations)[stable]
(cur)(last)11:32, October 10, 2009Wraasch (Talk | contribs) (→Patent expirations)[stable]
(cur)(last)10:37, October 10, 2009Wraasch (Talk | contribs)[stable]
(cur)(last)10:35, October 10, 2009Wraasch (Talk | contribs) (→Aging Population)[stable]
(cur)(last)10:33, October 10, 2009Wraasch (Talk | contribs) (→Vaccines (GBP 2.5 Billion))[stable]
(cur)(last)10:30, October 10, 2009Wraasch (Talk | contribs) (→Flu Pandemics/Epidemics)[stable]
(cur)(last)15:36, September 26, 2009Wraasch (Talk | contribs) (→Flu Pandemics/Epidemics)[stable]
(cur)(last)15:30, September 26, 2009Wraasch (Talk | contribs) (→Comparison to Competitors)[stable]
(cur)(last)06:41, August 24, 2009Wshikani (Talk | contribs) (→Trends and Forces)[stable]
(cur)(last)06:37, August 24, 2009Wshikani (Talk | contribs) (→Vaccines (GBP 2.5 Billion))[stable]
(cur)(last)17:25, July 19, 2009Wraasch (Talk | contribs)m (→Products and Revenue)[stable]
(cur)(last)07:53, July 4, 2009Wshikani (Talk | contribs)m[stable]
(cur)(last)07:52, July 4, 2009Wshikani (Talk | contribs)[stable]
(cur)(last)21:24, June 29, 2009Wikinvest MaintenanceBot (Talk | contribs) (Hiding Logos)
(cur)(last)13:21, June 22, 2009Walim (Talk | contribs) (→References)[stable]
(cur)(last)08:33, May 30, 2009Wshikani (Talk | contribs) (→Comparison to Competitors)[stable]
(cur)(last)21:41, May 19, 2009Wshikani (Talk | contribs)[stable]
(cur)(last)21:31, May 19, 2009Wshikani (Talk | contribs) (→Business Growth)[stable]
(cur)(last)21:49, March 9, 2009127.0.0.1 (Talk) (Seeding Wikicomps)
(cur)(last)14:44, February 28, 2009Wraasch (Talk | contribs)m (→Prescription Medication ($37.1 Billion))[stable]
(cur)(last)10:31, December 8, 2008Smarttutor (Talk | contribs)m (Reverted edits by Invest2success (Talk); changed back to last version by Wshikani)[stable]
(cur)(last)23:52, December 7, 2008Invest2success (Talk | contribs)
(cur)(last)15:22, December 7, 2008Wshikani (Talk | contribs) (→Prescription Medication ($37.1 Billion))[stable]
(cur)(last)15:20, December 7, 2008Wshikani (Talk | contribs) (→Prescription Medication ($37.1 Billion))[stable]
(cur)(last)23:49, November 24, 2008Kavita (Talk | contribs) (Seeding Wikicomps)
(cur)(last)15:09, October 30, 2008Smarttutor (Talk | contribs) (Seeding Wikicomps)[stable]
(cur)(last)19:45, July 29, 2008Bpan (Talk | contribs) (→Business Growth)
(cur)(last)19:42, July 29, 2008Bpan (Talk | contribs) (→Business Growth)
(cur)(last)09:49, July 18, 2008Mybikeisgreen4 (Talk | contribs)
(cur)(last)11:57, June 17, 2008Bpan (Talk | contribs) (→Consumer Health Care ($6.4 Billion))
(cur)(last)16:45, April 30, 2008Dclevela (Talk | contribs) (→Business Growth)
(cur)(last)16:44, April 30, 2008Dclevela (Talk | contribs) (→Business Growth)
(cur)(last)01:56, April 28, 2008Bpan (Talk | contribs)
(cur)(last)01:49, April 28, 2008Bpan (Talk | contribs) (→Business Growth)
(cur)(last)02:55, April 24, 2008Bpan (Talk | contribs) (→Business Growth)
(cur)(last)02:50, April 24, 2008Bpan (Talk | contribs)
(cur)(last)02:47, April 24, 2008Bpan (Talk | contribs) (→Research and Development)
(cur)(last)02:46, April 24, 2008Bpan (Talk | contribs)
(cur)(last)02:44, April 24, 2008Bpan (Talk | contribs) (→Corporate Overview)
(cur)(last)03:19, April 5, 2008Wikinvest MaintenanceBot (Talk | contribs) (Adding references)
(cur)(last)03:19, April 5, 2008Wikinvest MaintenanceBot (Talk | contribs) (Adding autowikidata)
(cur)(last)23:59, April 3, 2008Wikinvest MaintenanceBot (Talk | contribs) (Adding categories)
(cur)(last)17:42, March 12, 2008Bpan (Talk | contribs) (→Comparison to Competitors)
(cur)(last)11:04, March 10, 2008Adamfarren (Talk | contribs) (→Vaccines ($3.4 Billion))
(cur)(last)11:03, March 10, 2008Adamfarren (Talk | contribs) (→Research and Development)
(Latest | Earliest) View (previous 50) (next 50)
Retrieved from "http://www.wikinvest.com/stock/GlaxoSmithKline_(GSK)"
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki